Invenomic Capital Management’s Lyell Immunopharma LYEL Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-43,576	Closed	-$1.94M	–	174
2024 Q1	$1.94M	Buy	43,576 +6,255	+17%	+$279K	0.1%	129
2023 Q4	$1.45M	Buy	+37,321	New	+$1.45M	0.07%	147